I think it would become much more difficult to do so because of the curtailed ability of the federal government to set regulations. Even pricing would be impacted. Outside of those provisions, the other TPP countries would have a say in our regulatory regime, in general. All parts of regulation and the creation of a potential new pharmacare program would be impacted by this deal.
Interestingly, in our experience in farm communities, we've spent the last nine years trying to save small rural hospitals and their emergency departments. We've been very active in my colleague's community here, trying to save the emergency department in the local hospital. In those communities, farmers often do not have third-party health insurance and do not have extended health benefits, so drug costs are already an enormous burden on families. Increasing drug costs would be a significant burden on those families as well.